22.04.2024 - Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial safety and tolerability data from its ongoing ... Seite 1

Related Keywords

United States , American , Rachel Mcminn , American Society For Gene , Nasdaq , Neurogene Inc , American Society , Cell Therapy , Chief Executive Officer ,